Paying users zone. Data is hidden behind hidden.

  • Get 1-month access to Regeneron Pharmaceuticals Inc. for $13.99, or

  • get full access to the entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Regeneron Pharmaceuticals Inc. (REGN)


Adjustments to Financial Statements

Advanced level


Adjustments to Current Assets

Regeneron Pharmaceuticals Inc., adjusted current assets

US$ in thousands

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Current assets hidden hidden hidden hidden hidden
Adjustments
Less: Current deferred tax assets1 hidden hidden hidden hidden hidden
After Adjustment
Adjusted current assets hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 Current deferred tax assets. See details »


Adjustments to Total Assets

Regeneron Pharmaceuticals Inc., adjusted total assets

US$ in thousands

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Total assets hidden hidden hidden hidden hidden
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1 hidden hidden hidden hidden hidden
Less: Current deferred tax assets2 hidden hidden hidden hidden hidden
Less: Noncurrent deferred tax assets3 hidden hidden hidden hidden hidden
After Adjustment
Adjusted total assets hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

2 Current deferred tax assets. See details »

3 Noncurrent deferred tax assets. See details »


Adjustments to Current Liabilities

Regeneron Pharmaceuticals Inc., adjusted current liabilities

US$ in thousands

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Current liabilities hidden hidden hidden hidden hidden
Adjustments
Less: Deferred revenue, current portion hidden hidden hidden hidden hidden
After Adjustment
Adjusted current liabilities hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).


Adjustments to Total Liabilities

Regeneron Pharmaceuticals Inc., adjusted total liabilities

US$ in thousands

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Total liabilities hidden hidden hidden hidden hidden
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)1 hidden hidden hidden hidden hidden
Less: Noncurrent deferred tax liabilities2 hidden hidden hidden hidden hidden
Less: Deferred revenue hidden hidden hidden hidden hidden
After Adjustment
Adjusted total liabilities hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Noncurrent deferred tax liabilities. See details »


Adjustments to Stockholders’ Equity

Regeneron Pharmaceuticals Inc., adjusted stockholders’ equity

US$ in thousands

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Stockholders’ equity hidden hidden hidden hidden hidden
Adjustments
Less: Net deferred tax assets (liabilities)1 hidden hidden hidden hidden hidden
Add: Deferred revenue hidden hidden hidden hidden hidden
After Adjustment
Adjusted stockholders’ equity hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 Net deferred tax assets (liabilities). See details »


Adjustments to Capitalization Table

Regeneron Pharmaceuticals Inc., adjusted capitalization table

US$ in thousands

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Capital and facility lease obligations, current portion hidden hidden hidden hidden hidden
Convertible senior notes, current portion hidden hidden hidden hidden hidden
Capital and facility lease obligations, excluding current portion hidden hidden hidden hidden hidden
Convertible senior notes, excluding current portion hidden hidden hidden hidden hidden
Total reported debt hidden hidden hidden hidden hidden
Stockholders’ equity hidden hidden hidden hidden hidden
Total reported capital hidden hidden hidden hidden hidden
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)1 hidden hidden hidden hidden hidden
Adjusted total debt hidden hidden hidden hidden hidden
Adjustments to Equity
Less: Net deferred tax assets (liabilities)2 hidden hidden hidden hidden hidden
Add: Deferred revenue hidden hidden hidden hidden hidden
Adjusted stockholders’ equity hidden hidden hidden hidden hidden
After Adjustment
Adjusted total capital hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Net deferred tax assets (liabilities). See details »


Adjustments to Revenues

Regeneron Pharmaceuticals Inc., adjusted revenues

US$ in thousands

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Revenues hidden hidden hidden hidden hidden
Adjustment
Add: Increase (decrease) in deferred revenue hidden hidden hidden hidden hidden
After Adjustment
Adjusted revenues hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).


Adjustments to Reported Income

Regeneron Pharmaceuticals Inc., adjusted net income

US$ in thousands

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
As Reported
Net income hidden hidden hidden hidden hidden
Adjustments
Add: Deferred income tax expense (benefit)1 hidden hidden hidden hidden hidden
Add: Increase (decrease) in deferred revenue hidden hidden hidden hidden hidden
Add: Other comprehensive income (loss), net of tax hidden hidden hidden hidden hidden
After Adjustment
Adjusted net income hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12).

1 Deferred income tax expense (benefit). See details »